Drug Shortage Report for POTASSIUM PHOSPHATES INJECTION, USP
Report ID | 10000 |
Drug Identification Number | 02139545 |
Brand name | POTASSIUM PHOSPHATES INJECTION, USP |
Common or Proper name | Potassium Phosphate |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM PHOSPHATE DIBASIC POTASSIUM PHOSPHATE MONOBASIC |
Strength(s) | 236MG 224MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 50mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2017-05-12 |
Actual start date | |
Estimated end date | 2017-06-09 |
Actual end date | 2017-05-26 |
Shortage status | Resolved |
Updated date | 2017-05-27 |
Company comments | Available at all locations Friday May 26th. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-05-27 | English | Compare |
v5 | 2017-05-25 | French | Compare |
v4 | 2017-05-25 | English | Compare |
v3 | 2017-05-13 | English | Compare |
v2 | 2017-05-10 | French | Compare |
v1 | 2017-05-10 | English | Compare |
Showing 1 to 6 of 6